Literature DB >> 6091446

Clinical applications of angiotensin-converting enzyme inhibitors.

R K Ferguson, P H Vlasses, H H Rotmensch.   

Abstract

Although only recently introduced, angiotensin-converting enzyme inhibitors have been utilized to treat a wide variety of clinical disorders. Their uses to date, approved by the Food and Drug Administration, have been in the treatment of refractory hypertension and congestive heart failure. However, they have been evaluated with mixed results in numerous other conditions in which the renin-angiotensin-aldosterone system may play a role. Their current status in the treatment of hypertension, congestive heart failure, and these other conditions is reviewed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091446     DOI: 10.1016/0002-9343(84)90367-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Kinetic analysis of the control through inhibition of autocatalytic zymogen activation.

Authors:  M C Manjabacas; E Valero; M García-Moreno; F García-Cánovas; J N Rodríguez; R Varón
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Kinetic behaviour of zymogen activation processes in the presence of an inhibitor.

Authors:  R Varón; M C Manjabacas; M García-Moreno; E Valero; F Garcia-Canovas
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

3.  Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

Authors:  G Waeber; T Fasanella d'Amore; J Nussberger; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

5.  Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: the influence of perindopril.

Authors:  G Brandenberger; J L Imbs; J P Libert; J Ehrhart; C Simon; J P Santoni; M Follenius
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

6.  Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs.

Authors:  R G Andersson; B E Karlberg; B R Lindgren; K Persson; U Rosenqvist
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 7.  Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review.

Authors:  B R Lindgren; R G Andersson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.